Logo image of REPL

REPLIMUNE GROUP INC (REPL) Stock Analyst Ratings

NASDAQ:REPL - US76029N1063 - Common Stock

5.4 USD
+0.02 (+0.37%)
Last: 8/29/2025, 8:00:01 PM
5.45 USD
+0.05 (+0.93%)
After Hours: 8/29/2025, 8:00:01 PM
Buy % Consensus

72

ChartMill assigns a Buy % Consensus number of 72% to REPL. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 7.29. This target is 34.92% above the current price.
REPL was analyzed by 15 analysts. The buy percentage consensus is at 72. So analysts seem to be have mildly positive about REPL.
In the last month the buy percentage fell by 13 points. So the trust of analysts is decreasing.
REPL was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
REPL Historical Analyst RatingsREPL Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -83 -75 -67 -59 -51 -43 -35 -27 -19 -11 -3 5 10 15

Price Target & Forecast

Price Low Median Mean High 5.402.024.087.2923.10 - -62.59% -24.44% 34.92% 327.78%
REPL Current Analyst RatingREPL Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6
Up and Down Grades
Date Firm Action Rating
2025-07-30 Cantor Fitzgerald Upgrade Neutral -> Overweight
2025-07-23 BMO Capital Downgrade Outperform -> Underperform
2025-07-23 Barclays Downgrade Overweight -> Equal-Weight
2025-07-23 HC Wainwright & Co. Downgrade Buy -> Neutral
2025-07-22 Leerink Partners Downgrade Outperform -> Market Perform
2025-07-22 Wedbush Downgrade Outperform -> Neutral
2025-07-22 JP Morgan Downgrade Overweight -> Neutral
2025-07-22 Jefferies Maintains Buy -> Buy
2025-07-16 JP Morgan Maintains Overweight -> Overweight
2025-07-03 HC Wainwright & Co. Reiterate Buy -> Buy
2025-06-20 Cantor Fitzgerald Initiate Overweight
2025-06-02 Piper Sandler Maintains Overweight -> Overweight
2025-02-26 JP Morgan Maintains Overweight -> Overweight
2025-02-13 HC Wainwright & Co. Maintains Buy -> Buy
2025-01-22 BMO Capital Maintains Outperform -> Outperform
2025-01-22 HC Wainwright & Co. Maintains Buy -> Buy
2024-12-04 Jefferies Maintains Buy -> Buy
2024-11-22 BMO Capital Maintains Outperform -> Outperform
2024-11-22 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-12 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-24 JP Morgan Maintains Overweight -> Overweight
2024-09-16 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-10 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-27 Roth MKM Initiate Buy
2024-08-13 JP Morgan Maintains Overweight -> Overweight
2024-06-07 Barclays Maintains Overweight -> Overweight
2024-06-07 HC Wainwright & Co. Maintains Buy -> Buy
2023-12-06 Barclays Maintains Overweight -> Overweight
2023-11-13 HC Wainwright & Co. Maintains Buy -> Buy
2023-11-08 Wedbush Reiterate Outperform -> Outperform